company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9087000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9087000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,580000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1095000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,525000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-855000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7742000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7742000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-533000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8397000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,50000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10958000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2078000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2078000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-51000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,385000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,334000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,334000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q3,2010-07-01,2010-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-5330000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,22661000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22661000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,530000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,740000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,552000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-30498000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6015000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6015000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-438000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4250000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,27000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12173000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7512000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7512000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-52000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,10000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,13000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9961000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9961000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11459000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2010.0,Q4,2010-10-01,2010-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,604000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,562000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,862000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,530000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-759000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8864000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8864000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-202000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3245000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,64000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8653000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5270000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5270000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12549000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,5000000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-7549000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-7549000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-4000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q1,2011-01-01,2011-03-31,2012-05-04 10:19:40+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11147000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10236000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,568000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,54000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,556000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9365000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9365000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35482000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,9741000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-12000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,35889000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,35877000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,35877000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q2,2011-04-01,2011-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,690000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8059000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-121000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-9490000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,4000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19959000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,10352000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,10352000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-9000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-23000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-23000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q3,2011-07-01,2011-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2267000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9370000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9370000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-106000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12650000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8044000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8044000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-14000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,143000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,129000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,129000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1198000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2011.0,Q4,2011-10-01,2011-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1560000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13516000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,544000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-25000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,660000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1216000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13553000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13553000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-42000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33388000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,11000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5912000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-27507000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-27507000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,15000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,51929000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,51914000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,51914000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,2000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q1,2012-01-01,2012-03-31,2013-05-03 08:51:31+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10856000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13773000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13773000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,529000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,562000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,410000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,313000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11959000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11959000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-80000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5995000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,145000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,15007000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9077000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9077000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1309000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1309000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q2,2012-04-01,2012-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4192000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15027000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,503000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,48000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,464000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3068000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-10944000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10944000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-71000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-18517000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,62000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24513000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5987000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5987000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9580000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9580000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4624000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16807000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,471000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,71000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2255000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13326000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13326000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-110000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11355000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,6928000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-4537000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-4537000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1339000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20912000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,19573000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,19573000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1710000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2012.0,Q4,2012-10-01,2012-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1384000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,468000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-660000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,708000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-384000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17200000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-162000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-53809000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7394000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-46577000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-46577000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-1338000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,115847000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,114509000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,114509000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q1,2013-01-01,2013-03-31,2014-05-01 08:50:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,50730000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,475000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-685000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,655000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,513000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18058000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18058000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-755000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-35036000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,21000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13188000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-22582000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-22582000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-9720000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,634000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-9086000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-9086000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-49727000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23140000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23140000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,479000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,970000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2221000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17454000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17454000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-984000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3555000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,10097000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5558000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5558000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-15000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,637000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,622000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,622000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22062000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22062000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,510000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,119000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1148000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5328000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14957000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14957000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2318000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19718000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8215000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13821000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-428000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,183982000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,183554000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,183554000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,154776000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2013.0,Q4,2013-10-01,2013-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,1209000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-29903000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-29903000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,579000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1876000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1250000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1925000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31875000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31875000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-195000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-112416000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31283000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-81328000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-81328000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,702000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,702000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,702000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q1,2014-01-01,2014-03-31,2015-04-29 08:29:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-112500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28274000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,582000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,947000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1511000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4378000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20856000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20856000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-899000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13806000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19304000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4599000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4599000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,154000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,154000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,154000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-2000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-16105000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28081000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28081000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,603000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,935000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1947000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1996000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26592000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26592000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-672000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19937000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38628000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18019000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18019000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,304000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,304000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,304000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-3000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8272000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31822000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31822000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,624000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2139000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,5671000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-22214000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-22214000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-163000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-2155000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,20017000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17699000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17699000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-1000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4505000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30174000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,672000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-894000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2281000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4474000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-32589000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-32589000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1561000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-120541000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,57067000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-65035000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-65035000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,191759000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,191759000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,191759000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,15000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q1,2015-01-01,2015-03-31,2016-05-05 08:43:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,94150000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32359000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32359000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,712000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,317000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2527000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4041000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24762000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24762000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1547000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43893000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29278000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-16162000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-16162000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,338000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,338000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,338000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40586000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31980000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,767000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1052000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3869000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1499000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27791000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27791000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1361000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-29381000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43004000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12262000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12262000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,736000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,736000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,736000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14793000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-32684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-32684000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,847000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1176000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4097000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,12819000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13745000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13745000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-407000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-12590000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,31741000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,18744000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,18744000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,318000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,318000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,318000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,5317000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34673000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34673000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,742000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2420000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4010000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7401000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34902000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34902000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-540000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48860000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74939000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,25539000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,25539000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,280000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,280000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,280000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:06:29+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9083000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31952000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,692000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,337000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3977000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6884000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-33830000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-33830000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-767000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-72994000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,74428000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,667000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,667000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2620000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2620000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2620000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-30543000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-34261000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-34261000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1366000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,201000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3539000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6107000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35262000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35262000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-374000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50961000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,73736000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,22401000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,22401000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12897000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12897000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12897000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 08:19:46+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,36000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28566000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28566000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1001000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,408000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3450000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,3016000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-20691000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-20787000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-942000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-41008000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,77734000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,35784000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,35784000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8668000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8668000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8668000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,23665000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26363000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1025000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-108000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10545000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9556000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-24457000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-24361000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-282000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30266000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,32213000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1665000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1665000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,11269000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,11269000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,11269000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11427000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3841000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3841000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-15680000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,0.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19521000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19521000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-190000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-48745000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35553000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13382000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13382000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,18456000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,18456000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,18456000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14447000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118132000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118132000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1028000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,69000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,111386000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-22373000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28022000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28022000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-259000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-31117000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,46871000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15495000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15495000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,12063000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,12063000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,12063000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 16:31:45+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-464000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16406000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16406000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,993000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-225000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3107000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4864000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17395000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17395000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-332000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-45785000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,59311000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13194000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13194000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8271000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,8271000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,8271000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,4070000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7243000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7243000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,835000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-286000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1894000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-9588000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14388000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14388000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-60000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74656000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,342000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,72153000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2221000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2221000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5538000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5538000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5538000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11071000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9403000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9403000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,721000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-382000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1802000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-8168000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15430000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15430000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-162000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19624000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23134000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3348000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3348000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3569000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3569000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3569000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8513000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17239000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1352000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-345000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3518000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-519000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-13233000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-13233000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-186000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-21404000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37886000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16296000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16296000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4160000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4160000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4160000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 16:16:18+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7223000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11779000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11779000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1153000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-307000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1446000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1555000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11042000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11042000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-298000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-37161000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,29500000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7959000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7959000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7212000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7212000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7212000.0
Celldex Therapeutics Inc,CLDX,,0000744218,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-11789000.0
